vs
Side-by-side financial comparison of BankUnited, Inc. (BKU) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
BankUnited, Inc. is the larger business by last-quarter revenue ($288.2M vs $185.2M, roughly 1.6× AMICUS THERAPEUTICS, INC.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 9.0%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.2%).
BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BKU vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $288.2M | $185.2M |
| Net Profit | — | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 31.2% | 8.6% |
| Net Margin | — | 0.9% |
| Revenue YoY | 9.0% | 23.7% |
| Net Profit YoY | — | -88.5% |
| EPS (diluted) | $0.89 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $288.2M | $185.2M | ||
| Q3 25 | $275.7M | $169.1M | ||
| Q2 25 | $273.9M | $154.7M | ||
| Q1 25 | $255.4M | $125.2M | ||
| Q4 24 | $264.5M | $149.7M | ||
| Q3 24 | $257.0M | $141.5M | ||
| Q2 24 | $250.2M | $126.7M | ||
| Q1 24 | $241.7M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $71.9M | $17.3M | ||
| Q2 25 | $68.8M | $-24.4M | ||
| Q1 25 | $58.5M | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $61.5M | $-6.7M | ||
| Q2 24 | $53.7M | $-15.7M | ||
| Q1 24 | $48.0M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 31.2% | 8.6% | ||
| Q3 25 | 35.5% | 20.3% | ||
| Q2 25 | 34.3% | -6.1% | ||
| Q1 25 | 31.4% | -6.3% | ||
| Q4 24 | 35.2% | 10.7% | ||
| Q3 24 | 32.4% | 15.3% | ||
| Q2 24 | 29.2% | 11.8% | ||
| Q1 24 | 27.8% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 26.1% | 10.2% | ||
| Q2 25 | 25.1% | -15.8% | ||
| Q1 25 | 22.9% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | 23.9% | -4.8% | ||
| Q2 24 | 21.5% | -12.4% | ||
| Q1 24 | 19.8% | -43.9% |
| Q4 25 | $0.89 | $0.00 | ||
| Q3 25 | $0.95 | $0.06 | ||
| Q2 25 | $0.91 | $-0.08 | ||
| Q1 25 | $0.78 | $-0.07 | ||
| Q4 24 | $0.91 | $0.05 | ||
| Q3 24 | $0.81 | $-0.02 | ||
| Q2 24 | $0.72 | $-0.05 | ||
| Q1 24 | $0.64 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $217.8M | $293.5M |
| Total DebtLower is stronger | $319.7M | $392.7M |
| Stockholders' EquityBook value | $3.1B | $274.2M |
| Total Assets | $35.0B | $949.9M |
| Debt / EquityLower = less leverage | 0.10× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.8M | $293.5M | ||
| Q3 25 | $559.5M | $263.8M | ||
| Q2 25 | $801.3M | $231.0M | ||
| Q1 25 | $443.7M | $250.6M | ||
| Q4 24 | $491.1M | $249.9M | ||
| Q3 24 | $889.9M | $249.8M | ||
| Q2 24 | $433.5M | $260.1M | ||
| Q1 24 | $421.2M | $239.6M |
| Q4 25 | $319.7M | $392.7M | ||
| Q3 25 | $320.4M | $392.0M | ||
| Q2 25 | $708.9M | $391.3M | ||
| Q1 25 | $709.1M | $390.7M | ||
| Q4 24 | $708.6M | $390.1M | ||
| Q3 24 | $708.7M | $389.5M | ||
| Q2 24 | $708.8M | $388.9M | ||
| Q1 24 | $709.0M | $388.4M |
| Q4 25 | $3.1B | $274.2M | ||
| Q3 25 | $3.0B | $230.4M | ||
| Q2 25 | $3.0B | $204.3M | ||
| Q1 25 | $2.9B | $193.6M | ||
| Q4 24 | $2.8B | $194.0M | ||
| Q3 24 | $2.8B | $178.8M | ||
| Q2 24 | $2.7B | $132.5M | ||
| Q1 24 | $2.6B | $130.7M |
| Q4 25 | $35.0B | $949.9M | ||
| Q3 25 | $35.1B | $868.8M | ||
| Q2 25 | $35.5B | $815.3M | ||
| Q1 25 | $34.8B | $789.8M | ||
| Q4 24 | $35.2B | $785.0M | ||
| Q3 24 | $35.8B | $786.6M | ||
| Q2 24 | $35.4B | $749.5M | ||
| Q1 24 | $35.1B | $721.8M |
| Q4 25 | 0.10× | 1.43× | ||
| Q3 25 | 0.11× | 1.70× | ||
| Q2 25 | 0.24× | 1.92× | ||
| Q1 25 | 0.24× | 2.02× | ||
| Q4 24 | 0.25× | 2.01× | ||
| Q3 24 | 0.25× | 2.18× | ||
| Q2 24 | 0.26× | 2.93× | ||
| Q1 24 | 0.27× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $358.6M | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $358.6M | $16.3M | ||
| Q3 25 | $99.7M | $35.7M | ||
| Q2 25 | $117.6M | $-26.5M | ||
| Q1 25 | $16.4M | $7.8M | ||
| Q4 24 | $433.8M | $-3.9M | ||
| Q3 24 | $46.1M | $-23.0M | ||
| Q2 24 | $135.7M | $22.7M | ||
| Q1 24 | $66.5M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | — | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 1.39× | 2.06× | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | 2.53× | — | ||
| Q1 24 | 1.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BKU
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
